VSee Health, Inc. Total Assets
VSee Health, Inc. (VSEE) had Total Assets of $16.73 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-14
- 2026-06-30: Assets $16.73M.
- 2026-03-31: Assets $19.02M.
- 2025-12-31: Assets $22.41M.
- 2025-09-30: Assets $18.71M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $16.73M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $19.02M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $22.41M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $18.71M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $18.21M 10-Q/A · filed 2025-11-20 | |
| 2025-03-31 | $19.40M 10-Q · filed 2025-10-15 | |
| 2024-12-31 | $19.99M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $22.30M 10-Q · filed 2025-11-14 | $25.03M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $78.59M 10-Q/A · filed 2025-11-20 | $78.99M 10-Q · filed 2024-09-23 |
| 2024-03-31 | $1.39M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $805.79K 10-K/A · filed 2025-08-29 | $1.37M 10-K · filed 2024-04-12 |
| 2023-09-30 | $8.14M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $8.08M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $7.67M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $7.63M 10-K · filed 2024-04-12 | |
| 2022-09-30 | $117.30M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $117.21M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $117.62M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $117.94M 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |